Daniel Gulbranson

Daniel Gulbranson

Senior Scientist, Alector Inc.
Cited by 3229
cell biology Alzheimer's disease CRISPR screening target discovery
Xueqiu Lin

Xueqiu Lin

Assistant Professor, Fred Hutch
Verified email at fredhutch.org
Cited by 2547
Computational Biology CRISPR screening Cancer Non-Coding Variants
Morito Kurata

Morito Kurata

Tokyo medical and Dental University (TMDU) 東京医科歯科大学病院基盤診療部門 病理部 …
Verified email at tmd.ac.jp
Cited by 2496
Pathology Bone marrow Microenvironment Drug resistance CRISPR screening
Tianlei Xu

Tianlei Xu

KSQ Therapeutics
Verified email at ksqtx.com
Cited by 2284
CRISPR screening Bioinformatics Epigenomics Genetics Applied Machine Learning
Ryan D Molony

Ryan D Molony

Postdoctoral Scholar, Novartis Institutes for Biomedical Research
Verified email at novartis.com
Cited by 1340
Cancer immunotherapy CRISPR screening
Jing Lu

Jing Lu

Second Hospital of Tianjin Medical University
Verified email at monash.edu
Cited by 1223
Antibiotics CRISPR screening Host-Pathogen-Drug interaction Neuroscience Alzheimer's disease
Meng Zhao

Meng Zhao

Westlake University
Verified email at westlake.edu.cn
Cited by 1056
heart regeneration stem cell therapy myocardial infarction neurodegenerative disease CRISPR screening
Xun Wang

Xun Wang

Caltech
Verified email at caltech.edu
Cited by 963
Single-cell Genomics CRISPR screening Systems Biology Bioinformatics and Computational Biology
Jiekun (Jackie) Yang

Jiekun (Jackie) Yang

MIT
Verified email at mit.edu
Cited by 913
Single-cell multi-omics Cancer genetics/epigenetics CRISPR screening Metabolism Down Syndrome
Hark Kyun Kim

Hark Kyun Kim

Postdoctoral Research Fellow, UCSD
Verified email at health.ucsd.edu
Cited by 789
Extracellular vesicles Alzheimer's disease Protein engineering CRISPR screening
1 - 10